BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30968591)

  • 1. Novel mutations of COL4A3, COL4A4, and COL4A5 genes in Chinese patients with Alport Syndrome using next generation sequence technique.
    Zhao X; Chen C; Wei Y; Zhao G; Liu L; Wang C; Zhang J; Kong X
    Mol Genet Genomic Med; 2019 Jun; 7(6):e653. PubMed ID: 30968591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome.
    Liu JH; Wei XX; Li A; Cui YX; Xia XY; Qin WS; Zhang MC; Gao EZ; Sun J; Gao CL; Liu FX; Wu QY; Li WW; Asan ; Liu ZH; Li XJ
    PLoS One; 2017; 12(5):e0177685. PubMed ID: 28542346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of heterozygous pathogenic COL4A3 or COL4A4 variants on patients with X-linked Alport syndrome.
    Zhang Y; Ding J; Zhang H; Yao Y; Xiao H; Wang S; Wang F
    Mol Genet Genomic Med; 2019 May; 7(5):e647. PubMed ID: 30883042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible Digenic Disease in a Caucasian Family with COL4A3 and COL4A5 Mutations.
    Choi M; Anistan YM; Eckardt KU; Gollasch M; Nickel P
    Nephron; 2019; 141(3):213-218. PubMed ID: 30661074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Digenic Alport Syndrome.
    Savige J; Renieri A; Ars E; Daga S; Pinto AM; Rothe H; Gale DP; Aksenova M; Cerkauskaite A; Bielska O; Lipska-Zietkiewicz B; Gibson JT
    Clin J Am Soc Nephrol; 2022 Nov; 17(11):1697-1706. PubMed ID: 35675912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving mutation screening in familial hematuric nephropathies through next generation sequencing.
    Morinière V; Dahan K; Hilbert P; Lison M; Lebbah S; Topa A; Bole-Feysot C; Pruvost S; Nitschke P; Plaisier E; Knebelmann B; Macher MA; Noel LH; Gubler MC; Antignac C; Heidet L
    J Am Soc Nephrol; 2014 Dec; 25(12):2740-51. PubMed ID: 24854265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The COL4A3 and COL4A4 Digenic Mutations in cis Result in Benign Familial Hematuria in a Large Chinese Family.
    Li A; Cui YX; Lv X; Liu JH; Gao EZ; Wei XX; Xia XY; Gao CL; Liu FX; Xia ZK; Asan ; Liu ZH; Li XJ
    Cytogenet Genome Res; 2018; 154(3):132-136. PubMed ID: 29742505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A3 and COL4A4 mutations and clinical characterization of 25 families.
    Nabais Sá MJ; Storey H; Flinter F; Nagel M; Sampaio S; Castro R; Araújo JA; Gaspar MA; Soares C; Oliveira A; Henriques AC; da Costa AG; Abreu CP; Ponce P; Alves R; Pinho L; Silva SE; de Moura CP; Mendonça L; Carvalho F; Pestana M; Alves S; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):456-61. PubMed ID: 25307543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COL4A3/COL4A4 mutations: from familial hematuria to autosomal-dominant or recessive Alport syndrome.
    Longo I; Porcedda P; Mari F; Giachino D; Meloni I; Deplano C; Brusco A; Bosio M; Massella L; Lavoratti G; Roccatello D; Frascá G; Mazzucco G; Muda AO; Conti M; Fasciolo F; Arrondel C; Heidet L; Renieri A; De Marchi M
    Kidney Int; 2002 Jun; 61(6):1947-56. PubMed ID: 12028435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Splicing Mutation Identified in a Chinese Family with X-linked Alport Syndrome Using Targeted Next-Generation Sequencing.
    Chen C; Lu CX; Wang Q; Cao LH; Luo Y; Zhang X
    Genet Test Mol Biomarkers; 2016 Apr; 20(4):203-7. PubMed ID: 26866448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autosomal recessive Alport syndrome: an in-depth clinical and molecular analysis of five families.
    Longo I; Scala E; Mari F; Caselli R; Pescucci C; Mencarelli MA; Speciale C; Giani M; Bresin E; Caringella DA; Borochowitz ZU; Siriwardena K; Winship I; Renieri A; Meloni I
    Nephrol Dial Transplant; 2006 Mar; 21(3):665-71. PubMed ID: 16338941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-Linked and Autosomal Recessive Alport Syndrome: Pathogenic Variant Features and Further Genotype-Phenotype Correlations.
    Savige J; Storey H; Il Cheong H; Gyung Kang H; Park E; Hilbert P; Persikov A; Torres-Fernandez C; Ars E; Torra R; Hertz JM; Thomassen M; Shagam L; Wang D; Wang Y; Flinter F; Nagel M
    PLoS One; 2016; 11(9):e0161802. PubMed ID: 27627812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole exome sequencing reveals novel COL4A3 and COL4A4 mutations and resolves diagnosis in Chinese families with kidney disease.
    Lin F; Bian F; Zou J; Wu X; Shan J; Lu W; Yao Y; Jiang G; Gale DP
    BMC Nephrol; 2014 Nov; 15():175. PubMed ID: 25381091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alport syndrome: impact of digenic inheritance in patients management.
    Fallerini C; Baldassarri M; Trevisson E; Morbidoni V; La Manna A; Lazzarin R; Pasini A; Barbano G; Pinciaroli AR; Garosi G; Frullanti E; Pinto AM; Mencarelli MA; Mari F; Renieri A; Ariani F
    Clin Genet; 2017 Jul; 92(1):34-44. PubMed ID: 27859054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of 47 novel mutations in patients with Alport syndrome and thin basement membrane nephropathy.
    Weber S; Strasser K; Rath S; Kittke A; Beicht S; Alberer M; Lange-Sperandio B; Hoyer PF; Benz MR; Ponsel S; Weber LT; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jun; 31(6):941-55. PubMed ID: 26809805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal recessive Alport's syndrome and benign familial hematuria are collagen type IV diseases.
    Tazón Vega B; Badenas C; Ars E; Lens X; Milà M; Darnell A; Torra R
    Am J Kidney Dis; 2003 Nov; 42(5):952-9. PubMed ID: 14582039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sixteen novel mutations identified in COL4A3, COL4A4, and COL4A5 genes in Slovenian families with Alport syndrome and benign familial hematuria.
    Slajpah M; Gorinsek B; Berginc G; Vizjak A; Ferluga D; Hvala A; Meglic A; Jaksa I; Furlan P; Gregoric A; Kaplan-Pavlovcic S; Ravnik-Glavac M; Glavac D
    Kidney Int; 2007 Jun; 71(12):1287-95. PubMed ID: 17396119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen type IV-related nephropathies in Portugal: pathogenic COL4A5 mutations and clinical characterization of 22 families.
    Nabais Sá MJ; Sampaio S; Oliveira A; Alves S; Moura CP; Silva SE; Castro R; Araújo JA; Rodrigues M; Neves F; Seabra J; Soares C; Gaspar MA; Tavares I; Freitas L; Sousa TC; Henriques AC; Costa FT; Morgado E; Sousa FT; Sousa JP; da Costa AG; Filipe R; Garrido J; Montalban J; Ponce P; Alves R; Faria B; Carvalho MF; Pestana M; Carvalho F; Oliveira JP
    Clin Genet; 2015 Nov; 88(5):462-7. PubMed ID: 25307721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unbiased next generation sequencing analysis confirms the existence of autosomal dominant Alport syndrome in a relevant fraction of cases.
    Fallerini C; Dosa L; Tita R; Del Prete D; Feriozzi S; Gai G; Clementi M; La Manna A; Miglietti N; Mancini R; Mandrile G; Ghiggeri GM; Piaggio G; Brancati F; Diano L; Frate E; Pinciaroli AR; Giani M; Castorina P; Bresin E; Giachino D; De Marchi M; Mari F; Bruttini M; Renieri A; Ariani F
    Clin Genet; 2014 Sep; 86(3):252-7. PubMed ID: 24033287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.